2013-00723. Privacy Act, Exempt Record System; Withdrawal  

  • Start Preamble

    AGENCY:

    Office of the Secretary, Food and Drug Administration, HHS.

    ACTION:

    Direct final rule; withdrawal.

    SUMMARY:

    The Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) are withdrawing the direct final rule that August 28, 2012. HHS/FDA published the direct final rule to exempt scientific research misconduct proceedings records from certain requirements of the Privacy Act of 1974 in order to protect records compiled in the course of misconduct inquiries and investigations, and to safeguard the identity of confidential sources. The comment period closed on November 13, 2012. HHS/FDA is withdrawing the direct final rule because the Agency received significant adverse comment.

    DATES:

    Effective Date: The direct final rule published at 77 FR 51910, August 28, 2012, is withdrawn effective January 10, 2013.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Frederick Sadler, Division of Freedom of Information, Food and Drug Administration, 12420 Parklawn Dr., Rockville, MD 20857, 301-796-8975, Frederick.Sadler@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    HHS and FDA are withdrawing the direct final rule that published in the Federal Register of Tuesday, August 28, 2012 (77 FR 51910). HHS/FDA published the direct final rule to exempt scientific research misconduct proceedings records from certain requirements of the Privacy Act of 1974 in order to protect records compiled in the course of misconduct inquiries and investigations, and to safeguard the identity of confidential sources. The comment period closed on November 13, 2012. HHS/FDA is withdrawing the direct final rule because the Agency received significant adverse comment.

    Start Authority

    Authority: Therefore, under 5 U.S.C. 552a, the direct final rule published on Tuesday, August 28, 2012, 77 FR 51910, is withdrawn.

    End Authority Start Signature

    Dated: January 10, 2013.

    Approved:

    Kathleen Sebelius

    Secretary, Department of Health and Human Services.

    End Signature End Supplemental Information

    [FR Doc. 2013-00723 Filed 1-10-13; 4:15 pm]

    BILLING CODE 4160-01-P

Document Information

Comments Received:
0 Comments
Published:
01/15/2013
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Direct final rule; withdrawal.
Document Number:
2013-00723
Pages:
2892-2892 (1 pages)
Docket Numbers:
Docket No. FDA-2011-N-0252
PDF File:
2013-00723.pdf
Supporting Documents:
» Patient Protection and Affordable Care Act: Benefit and Payment Parameters for 2022; Updates to State Innovation Waiver Implementing Regulations
» Guidance: Good Guidance Practices; Correction
» National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury Table
» Amendments to the HHS-Operated Risk Adjustment Data Validation Under the Patient Protection and Affordable Care Act's HHS-Operated Risk Adjustment Program
» Transparency in Coverage
» UA: Reg Flex Agenda
» Medicare and Medicaid Programs: CY 2020 Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates; Price Transparency Requirements for Hospitals to Make Standard Charges Public
» Administrative Simplification: Rescinding the Adoption of the Standard Unique Health Plan Identifier and Other Entity Identifier
» Protecting Statutory Conscience Rights in Health Care; Delegations of Authority
» Patient Protection and Affordable Care Act: Increasing Consumer Choice through the Sale of Individual Health Insurance Coverage Across State Lines Through Health Care Choice Compacts
CFR: (2)
21 CFR 21
45 CFR 5